companydata.dkcompanydata.dk

Pharma Equity Group A/S: Financial statements 2018

CVR: 26791413

Source: annual report 2018, Danish Business Authority

01/01/2018 – 31/12/2018

Pharma Equity Group A/S (CVR 26791413) has filed annual accounts for 2018. In 2018, the company reported a net result of DKK -7,713,000 compared with DKK -4,077,000 the year before. Equity in the 2018 report amounted to DKK 77,572,000. The solvency ratio was 96%.

Profit/Loss
DKK -7,713,000
Equity
DKK 77,572,000
Total Assets
DKK 80,838,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018---7.7 mio.77.6 mio.-
2017---4.1 mio.103.3 mio.-
2016---2 mio.96.8 mio.-
2015---3.7 mio.99.5 mio.-
201400-5.9 mio.98 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

Pharma Equity Group A/S publishes interim reportOct 24, 2018

Pharma Equity Group A/S has published its interim report for the period January 1, 2018 – June 30, 2018.

Pharma Equity Group A/S: The 2017 annual report is outMay 22, 2018

Pharma Equity Group A/S has published its annual report for 2017. The net result was DKK -4,077,000.

Pharma Equity Group A/S appoints new auditorApr 30, 2018

As of April 30, 2018, Morten Søndergaard Schwensen has been appointed auditor of Pharma Equity Group A/S.

Pharma Equity Group A/S appoints new auditorApr 30, 2018

As of April 30, 2018, Peter Aagesen has been appointed auditor of Pharma Equity Group A/S.

Pharma Equity Group A/S appoints new auditorApr 30, 2018

As of April 30, 2018, AIDER Godkendt Revisionsaktieselskab has been appointed auditor of Pharma Equity Group A/S.

Auditor steps down at Pharma Equity Group A/SApr 30, 2018

As of April 30, 2018, Peter Aagesen has stepped down as auditor of Pharma Equity Group A/S.

Auditor steps down at Pharma Equity Group A/SApr 30, 2018

As of April 30, 2018, KPMG P/S has stepped down as auditor of Pharma Equity Group A/S.

Peer Henning Borg joins the board of Pharma Equity Group A/SApr 30, 2018

As of April 30, 2018, Peer Henning Borg has joined the board of directors of Pharma Equity Group A/S.

Nicolai Dines Kærgaard joins the board of Pharma Equity Group A/SApr 30, 2018

As of April 30, 2018, Nicolai Dines Kærgaard has joined the board of directors of Pharma Equity Group A/S.

Niels Troen leaves the board of Pharma Equity Group A/SApr 30, 2018

As of April 30, 2018, Niels Troen has left the board of directors of Pharma Equity Group A/S.

About Pharma Equity Group A/S

Pharma Equity Group A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2002. The company is registered under the industry Investering for egen regning. The company was previously named BLUE VISION A/S and GUDME RAASCHOU VISION A/S. The management consists of Christian Henrik Tange. The board consists of Christian Vinding Thomsen (chair), Charlotte Pahl, Lars Rosenkrantz Gundorph and Omar Siraj M Qandeel. The company's owners include NIELS ERIK JESPERSEN HOLDING ApS, Beier Holding ApS and FINANSMANAGEMENT ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK 0. Equity in the 2025 report amounted to DKK 25,472,000.

Source: annual report 2025, Danish Business Authority